Health-Care and Societal Costs Associated With Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA) – A Retrospective Observational Study
posted on 2022-02-10, 14:56authored byJohan Dalén, Anushri Chitkara, Axel Svedbom, Tor Olofsson, Amy Puenpatom, Christopher M. Black, Zaina P. Qureshi
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).